03.16.26 -- Not So Fast Into The Night: Your Outsourcing Needs A Pause

Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

Cell and gene therapies hold immense promise for complex diseases. However, manufacturing at scale and managing global delivery chains remain significant challenges for developers to address.

Discover how to achieve scalable, cost-effective, and high-quality lentiviral vector production. Analyze methods to accelerate development timelines for both ex vivo and in vivo CAR-T therapies.

As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.

Applying established vaccine manufacturing principles to cell and gene therapy can improve production efficiency. Explore how these cross-industry lessons impact safety, cost, and product quality.

Standardization is essential for minimizing risk in complex supply chains. Ensure product integrity and navigate the growing regulatory requirements across global manufacturing networks.

Platform-based manufacturing uses standardized, pre-qualified workflows and analytics that reduce variability, simplify regulatory submissions, and accelerate the path to commercial success.

Whether you’re at the discovery stage or thinking about commercial production, gain useful insights on expression formats from transient transfection, through stable pools to stable clones.